AbbVie

Open: 149.71 Close: 150.16 Change: 0.45

You don't have read the whole internet to decide whether to invest in AbbVie. Use an AI.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: migraine, AbbVie, European, Commission, day, month, price, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

European Commission approves AQUIPTA for the prophylaxis of migraine in adults who have four or more migraine days per month. European Commission approval is a significant milestone for people suffering from four. or more migraines.

Today's News

European Commission approves AQUIPTA for the prophylaxis of migraine in adults who have four or more migraine days per month. European Commission approval is a significant milestone for people suffering from four. or more migraines. Yes link below will take you out of the AbbVie family of websites. The European Commission approval of AQUIPTA is a significant milestone for people suffering from four or more migraine days per month as it provides a once-daily treatment option that can reduce the number of migraine days. AbbVie stock price is 150.14 USD today. Share price is forecast to RISE/FALL based on technical indicators. According to simple moving average, exponential moving average and oscillators, Abbvie is not overvalued. Whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Whales have been targeting a price range from $95.0 to $165.0 over the last 3 months. Ironwood and AbbVie share equally in U.S. net sales as reported by Abbvie. In the United States, Ironwood co-develop and co-commercialize LINZESS. European Commission approves AbbVies (ABBV) Aquipta for migraine. Zacks Equity Research: What to Look Out for by Zacks. AbbVie (ABBV) to Report a Decline in Earnings: What To Look out for. AbbVie Inc is Overvalued by 19% compared to the current market price of 150.16 USD. The European Commission recently approved Abbvies atogepant (Aquipta) for the prophylaxis of migraine in adults who have 4 or more migraine days per month.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: migraine, AbbVie, European, Commission, day, month, price, and the most common words in the summary are: abbvie, stock, abbv, market, price, news, change, . One of the sentences in the summary was: European Commission approval is a significant milestone for people suffering from four. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #abbv #market #price #news #change.